ARRDC3 and esophageal squamous cell carcinoma: Also, overexpression of ARRDC3 confers breast cancer cell chemotherapy resistance [13], which were in parallel with our present result that upregulated ARRDC3 diminished the ESCC cell resistance to CIS and PT.